5.46 - 5.56
4.95 - 8.28
1.3K / 2.4K (Avg.)
-277.00 | -0.02
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
0.45%
Revenue growth under 50% of STERV.HE's 2.90%. Michael Burry would suspect a deteriorating sales pipeline or weaker brand.
0.45%
Positive gross profit growth while STERV.HE is negative. John Neff would see a clear operational edge over the competitor.
-106.06%
Negative EBIT growth while STERV.HE is at 116.07%. Joel Greenblatt would demand a turnaround plan focusing on core profitability.
-106.06%
Negative operating income growth while STERV.HE is at 116.07%. Joel Greenblatt would press for urgent turnaround measures.
-157.89%
Negative net income growth while STERV.HE stands at 61.59%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-156.42%
Negative EPS growth while STERV.HE is at 56.00%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-156.42%
Negative diluted EPS growth while STERV.HE is at 56.00%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-228.57%
Negative OCF growth while STERV.HE is at 0.94%. Joel Greenblatt would demand a turnaround plan focusing on real cash generation.
-100.00%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
6.92%
Positive 10Y revenue/share CAGR while STERV.HE is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
6.92%
Positive 5Y CAGR while STERV.HE is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
6.92%
Positive 3Y CAGR while STERV.HE is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
-142.78%
Both show negative 10Y OCF/share CAGR. Martin Whitman would question if the entire market or product set is shrinking or too capital-intensive.
-142.78%
Negative 5Y OCF/share CAGR while STERV.HE is at 119.94%. Joel Greenblatt would question the firm’s operational model or cost structure.
-142.78%
Negative 3Y OCF/share CAGR while STERV.HE stands at 39.18%. Joel Greenblatt would demand an urgent turnaround in the firm’s cost or revenue drivers.
68.48%
Net income/share CAGR 1.25-1.5x STERV.HE's 61.98%. Bruce Berkowitz might see more effective use of capital or consistently better margins over time.
68.48%
Below 50% of STERV.HE's 227.51%. Michael Burry would worry about a substantial lag vs. the competitor’s profit ramp-up.
68.48%
Below 50% of STERV.HE's 330.76%. Michael Burry suspects a steep short-term disadvantage in bottom-line expansion.
5.73%
Positive growth while STERV.HE is negative. John Neff might see a strong advantage in steadily compounding net worth over a decade.
5.73%
Positive 5Y equity/share CAGR while STERV.HE is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
5.73%
Positive short-term equity growth while STERV.HE is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
2.09%
Inventory growth well above STERV.HE's 3.68%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
-2.20%
Negative asset growth while STERV.HE invests at 3.25%. Joel Greenblatt checks if the competitor might capture more market share unless our returns remain higher.
-1.19%
We have a declining book value while STERV.HE shows 8.17%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
-0.74%
We’re deleveraging while STERV.HE stands at 5.51%. Joel Greenblatt considers if we gain a balance-sheet advantage for potential downturns.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.